Evaluation of an 18F-labeled oligonucleotide probe targeting p21WAF1 transcriptional changes in human tumor cells

Oncology Research

Volumn 19, Issue 6, 2011, Pages 265-274

  Koslowsky, I ^a   Shahhosseini, S ^b   Mirzayans, R ^c   Murray, D ^c   Mercer, John R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Edmonton Radiopharmaceutical Centre   (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

Author keywords

Antisense oligonucleotide; Fluorine 18; HCT116; Ionizing radiation; p21

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FLUORINE 18; MESSENGER RNA; PROTEIN P21; CDKN1A PROTEIN, HUMAN; COBALT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ANTISENSE THERAPY; ARTICLE; BINDING AFFINITY; CANCER RADIOTHERAPY; CELL FRACTIONATION; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG UPTAKE; ENDOSOME; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IONIZING RADIATION; LIPOSOMAL GENE DELIVERY SYSTEM; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RNA TRANSCRIPTION; SENESCENCE; WESTERN BLOTTING; CELL AGING; COLON TUMOR; DRUG COMBINATION; EVALUATION; GENETICS; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL CULTURE;

BLOTTING, WESTERN; CELL AGING; COBALT RADIOISOTOPES; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG THERAPY, COMBINATION; FLUORINE RADIOISOTOPES; GENE EXPRESSION; HUMANS; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE PROBES; OLIGONUCLEOTIDES, ANTISENSE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 80051610564     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504011X13021877989793     Document Type: Article

References (33)

1. Appella, E.; Anderson, C. W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764-2772; 2001.
2. 1 arrest and apoptosis. Cancer Res. 54:1169-1174; 1994.
3. Mazzatti, D. J.; Lee, Y.; Helt, C. E.; O'Reilly, M. A.; Keng, P. C. p53 modulates radiation sensitivity independent of p21 transcriptional activation. Am. J. Clin. Oncol. Cancer Clin. Trials 28:43-50; 2005.
4. Jänicke, R. U.; Sohn, D.; Essmann, F.; Schulze-Osthoff, K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 6:407-413; 2007.
5. Belka, C. The fate of irradiated tumor cells. Oncogene 25: 969-971; 2006.
6. CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells. Oncogene 25:972-980; 2006.
7. Mirzayans, R.; Scott, A.; Cameron, M.; Murray, D. Induction of accelerated senescence by γ radiation in human solid tumor-derived cell lines expressing wild-type TP53. Radiat. Res. 163:53-62; 2005.
8. Stein, C. A. The experimental use of antisense oligonucleotides: A guide for the perplexed. J. Clin. Invest. 108: 641-644; 2001.
9. Poluha, W.; Poluha, D. K.; Chang, B.; Crosbie, N. E.; Schonhoff, C. M.; Kilpatrick, D. L.; Ross, A. H. The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1335-1341; 1996.
10. WAF1/CIP1 antisense therapy radiosensitizes human colon cancer byconverting growth arrest to apoptosis. Cancer Res. 60: 679-684; 2000.
11. 18F]fluorobenzyl)-2- bromoacetamide: An F-18-labeled reagent for the prosthetic radiolabeling of oligonucleotides. J. Label. Compd. Radiopharm. 51:352-356; 2008.
12. Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: A highly efficient lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417; 1987.
13. Eboue, D.; Auger, R.; Angiari, C.; Le Doan, T.; Tenu, J. P. Use of a simple fractionation method to evaluate binding, internalization and intracellular distribution of oligonucleotides in vascular smooth muscle cells. Arch. Physiol. Biochem. 111:265-272; 2003.
14. 18F-labelled spiegelmers: A new class of oligonucleotidic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 32:470-477; 2005.
15. Marzabal, S.; Terrazzino, S.; Kühnast, B.; Dollé, F.; Deverre, J. R.; Jobert, A.; Crouzel, C.; Di Giamberardino, L.; Tavitian, B. In vivo imaging and pharmacokinetics of oligonucleotides. Nucleosides Nucleotides 18:1731-1733; 1999.
16. Tavitian, B.; Terrazzino, S.; Kühnast, B.; Marzabal, S.; Stettler, O.; Dollé, F.; Deverre, J.; Jobert, A.; Hinnen, F.; Bendriem, B. Crouzel, C.; Di Giamberardino, L. In vivo imaging of oligonucleotides with positron emission to mography. Nat. Med. 4:467-470; 1998.
17. WAF1/CIP1. Cancer Gene Ther. 10:926-934; 2003.
18. Ohtsubo, M.; Gamou, S.; Shimizu, N. Antisense oligonu-cleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells. Oncogene 16:797-802; 1998.
19. CIP1 modulate cell survival of drug-induced senescent tumor cells: Implications for chemotherapy. Clin. Cancer Res. 14:1877-1887; 2008.
20. Li, B.; Hughes, J. A.; Phillips, M. I. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells. Neurochem. Int. 31:393-403; 1997.
21. Galderisi, U.; Di Bernardo, G.; Melone, M. A. B.; Galano, G.; Cascino, A.; Giordano, A.; Cipollaro, M. Antisense inhibitory effect: A comparison between 3′-partial and full phosphorothioate antisense oligonucleotides. J. Cell. Biochem. 74:31-37; 1999.
22. Lebedeva, I.; Benimetskaya, L.; Stein, C. A.; Vilenchik, M. Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 50:101-119; 2000.
23. 18F]fluorobenzylamine: A versatile building block for the preparation of PET radiotracers. Org. Biomol. Chem. 8:4730-4735; 2010.
24. 18F]fluorobenzoate. Acta Chem. Scand. 52:1034-1039; 1998.
25. 18F]fluorobenzoate (S18FB). J. Label. Compd. Radiopharm. 49: 1213-1221; 2006.
26. 18F]fluoropyridin-3-yloxy)propyl]- acetamide. Bioconjugate Chem. 15:617-627; 2004.
27. 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation. Appl. Radiat. Isot. 67:1670-1675; 2009.
28. Viel, T.; Kuhnast, B.; Hinnen, F.; Boisgard, R.; Tavitian, B.; Dollé, F. Fluorine-18 labelling of small interfering RNAs (siRNAs) for PET imaging. J. Label. Compd. Radiopharm. 50:1159-1168; 2007.
29. 18F]Fluoropyridines: From conventional radio- tracers to the labeling of macromolecules such as proteins and oligonucleotides. Ernst Schering Res. Found. Workshop, 113-157; 2007.
30. Hnatowich, D. J.; Nakamura, K. Antisense targeting in cell culture with radiolabeled DNAs - a brief review of recent progress. Ann. Nucl. Med. 18:363-368; 2004.
31. Zelphati, O.; Szoka, Jr., F. C. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: A real or magic bullet? J. Control. Release 41:99-119; 1996.
32. Lorenz, P.; Baker, B. F.; Bennett, C. F.; Spector, D. L. Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies. Mol. Biol. Cell 9:1007-1023; 1998.
33. Lorenz, P.; Misteli, T.; Baker, B. F.; Bennett, C. F.; Spector, D. L. Nucleocytoplasmic shuttling: A novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 28:582-592; 2000.